Avricore Health (AVCRF) Exchange Rate Effect (2011 - 2025)

Avricore Health (AVCRF) posted quarterly Exchange Rate Effect of -$384.39 for Q3 2025, down 948.74% YoY from $45.29 in Q3 2024, and up 30.47% sequentially from -$552.83 in Q2 2025.

Avricore Health (AVCRF) Exchange Rate Effect (2011 - 2025) Analysis & Trends

Avricore Health has disclosed Exchange Rate Effect across 3 years of filings, most recently posting -$384.39 for Q3 2025.

  • In Q3 2025, Exchange Rate Effect fell 948.74% year-over-year to -$384.39; the TTM figure through Sep 2025 stood at -$803.13 (changed N/A YoY), while the FY2025 annual figure was -$128.11, down 273.2% from the prior year.
  • Exchange Rate Effect advanced to -$384.39 in Q3 2025, from -$552.83 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for AVCRF reached as high as $170.74 in Q1 2025 and fell as low as -$552.83 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FX Effect (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn -5.00 Mn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn 78.00 Mn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn -33.00 Mn
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn -816,000.00
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn -
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn -7.00 Mn
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn -22.00 Mn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn -1.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn -426,000.00
10 Avricore Health - - - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -384.39
Sep 30, 2025 -384.39
Jun 30, 2025 -552.83
Jun 30, 2025 -552.83
Mar 31, 2025 170.74
Mar 31, 2025 170.74
Sep 30, 2024 -36.65
Sep 30, 2024 -36.65
Dec 31, 2012 1,523.89
Dec 31, 2012 1,523.89
Sep 30, 2012 2,076.45
Sep 30, 2012 2,076.45
Dec 31, 2011 744.50
Dec 31, 2011 744.50
Sep 30, 2011 4,401.06
Sep 30, 2011 4,401.06